Journals / Diagnostic and Interventional Radiology / 2020 / Cilt: 26 - Sayı: 5

Discrimination of papillary renal cell carcinoma from benign proteinaceous cyst based on iodine and water content on rapid kV-switching dual-energy CT

Pages
390–395
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Despite having a high sensitivity, water content has inferior diagnostic accuracy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:PURPOSE We aimed to evaluate whether rapid kV-switching dual energy CT (rsDECT) can discriminate between papillary renal cell carcinoma (RCC) and benign proteinaceous cysts (BPCs) based on iodine and water content.
📊
Key Findings & Data:METHODS Twenty-four patients with histopathologically proven papillary RCC and 38 patients with 41 BPCs were retrospectively included.
💡
Conclusion & Impact:Despite having a high sensitivity, water content has inferior diagnostic accuracy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

PURPOSE We aimed to evaluate whether rapid kV-switching dual energy CT (rsDECT) can discriminate between papillary renal cell carcinoma (RCC) and benign proteinaceous cysts (BPCs) based on iodine and water content. METHODS Twenty-four patients with histopathologically proven papillary RCC and 38 patients with 41 BPCs were retrospectively included. Patients with BPCs were eligible for inclusion when the cysts were stable in size and appearance for at least 2 years or proved to be a cyst on ultrasound or MRI. All patients underwent delayed phase (70–90 s) rsDECT. Iodine and water content of each lesion was measured on the workstation. RESULTS Of papillary RCC patients, 4 (16%) were female and 20 (84%) were male. Mean tumor size was 39±20 mm. Mean iodine and water content was 2.08±0.7 mg/mL and 1021±14 mg/mL, respectively. Of BPC patients, 9 were female and 29 were male. Mean cyst size was 20±7 mm. Mean iodine and water content was 0.82±0.4 mg/mL and 1012±14 mg/mL, respectively. There were significant differences between iodine and water contents of papillary RCCs and BPCs (P < 0.001). The best cutoff of iodine content for differentiating papillary RCC from BPC was 1.21 mg/mL (area under the curve [AUC]=0.97, P < 0.001, sensitivity 96%, specificity 88%, positive predictive value [PPV] 82%, negative predictive value [NPV] 97%, accuracy 91%,); the best cutoff of water content was 1015.5 mg/mL (AUC=0.68, P = 0.016, sensitivity 83%, specificity 56%, PPV 52%, NPV 85%, accuracy 66%). CONCLUSION An iodine content threshold of 1.21 mg/mL accurately differentiates papillary RCC from BPCs on a single postcontrast rsDECT. Despite having a high sensitivity, water content has inferior diagnostic accuracy.

🔖

Cite This Article

ÇAMLIDAĞ, İ., NURAL, M. S., KALKAN, C., DANACI, M. (2020). Discrimination of papillary renal cell carcinoma from benign proteinaceous cyst based on iodine and water content on rapid kV-switching dual-energy CT. Diagnostic and Interventional Radiology, Cilt: 26 - Sayı: 5, 390–395. https://ajindex.com/articles/152502

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Israel GM, Bosniak MA. How I do it: evaluating renal masses. Radiology 2005; 236:441–450. [Crossref] 2. Jonisch AI, Rubinowitz AN, Mutalik PG, Israel GM. Can high-attenuation renal cysts be differentiated from renal cell carcinoma at unenhanced CT? Radiology 2007; 243:445–450. [Crossref] 3. Siddaiah M, Krishna S, McInnes MDF, et al. Is Ultrasound Useful for Further Evaluation of Homogeneously Hyperattenuating Renal Lesions Detected on CT? AJR Am J Roentgenol 2017; 209:604–610. [Crossref] 4. Gill IS, Aron M, Gervais DA, Jewett MA. Clinical practice. Small renal mass. N Engl J Med 2010; 362:624–634. [Crossref] 5. Lindblad P. Epidemiology of renal cell carcinoma. Scand J Surg 2004; 93:88–96. [Crossref] 6. Agrawal MD, Pinho DF, Kulkarni NM, Hahn PF, Guimaraes AR, Sahani DV. Oncologic applications of dual-energy CT in the abdomen. Radiographics 2014; 34:589–612. [Crossref] 7. Kaza RK, Caoili EM, Cohan RH, Platt JF. Distinguishing enhancing from nonenhancing renal lesions with fast kilovoltage-switching dual-energy CT. AJR Am J Roentgenol 2011; 197:1375–1381. [Crossref] 8. Marin D, Boll DT, Mileto A, Nelson RC. State of the art: dual-energy CT of the abdomen. Radiology 2014; 271:327–342. [Crossref] 9. Jacobsen MC, Schellingerhout D, Wood CA, et al. Intermanufacturer comparison of dual-energy CT iodine quantification and monochromatic attenuation: a phantom study. Radiology 2017:170896. 10. McCollough CH, Leng S, Yu L, Fletcher JG. Dual-and multi-energy CT: principles, technical approaches, and clinical applications. Radiology 2015; 276:637–653. [Crossref] 11. Ascenti G, Mazziotti S, Mileto A, et al. Dual-source dual-energy CT evaluation of complex cystic renal masses. AJR Am J Roentgenol 2012; 199:1026–1034. [Crossref] 12. Chandarana H, Megibow AJ, Cohen BA, et al. Iodine quantification with dual-energy CT: phantom study and preliminary experience with renal masses. AJR Am J Roentgenol 2011; 196:W693–700. [Crossref] 13. Mileto A, Marin D, Ramirez-Giraldo JC, et al. Accuracy of contrast-enhanced dual-energy MDCT for the assessment of iodine uptake in renal lesions. AJR Am J Roentgenol 2014; 202:W466–474. [Crossref] 14. Zarzour JG, Milner D, Valentin R, et al. Quantitative iodine content threshold for discrimination of renal cell carcinomas using rapid kV-switching dual-energy CT. Abdom Radiol 2017; 42:727–734. [Crossref] 15. Couvidat C, Eiss D, Verkarre V, et al. Renal papillary carcinoma: CT and MRI features. Diagn Interv Imaging 2014; 95:1055–1063. [Crossref